Find anything about our product, search our documentation, and more. Enter a query in the search input above, and results will be displayed as you type.
Searching... 
Twist Bioscience
San Francisco, CA
Global Life Science & Healthcare
We help companies advancing the future of healthcare scale effectively at every stage of growth.
Our Expertise
- Biopharma
- HealthTech
- Medical Devices
- Healthcare Services
- Diagnostics and Tools
We work with companies just like yours
Our clients consist of the top companies and investors across key sectors of life sciences and healthcare.
*All companies listed above are independent third parties and not affiliated with SVB Financial Group.
Dedicated team
Over 100 global life science and healthcare experts in North America, Europe, and China
Our global footprint provides insight into and access to markets, companies, and investors not accessible otherwise for clients to learn from and engage to improve their business.
Katherine Andersen
|
Head of Life Science & Healthcare
Katherine serves as Head of Life Science & Healthcare and sits on the board of SVB's joint venture in China, SPD Silicon Valley Bank.
Peter Benham
|
Head of Healthcare Corporate Banking
Peter leads SVB's Healthcare Corporate Banking practice. In this role he oversees SVB’s relationships with public and late stage private companies in the life science and healthcare sector.
Gregory Pachus
|
Head of Healthcare Leveraged Finance & Sponsor Coverage
Greg leads SVB's Healthcare Leverage Finance & Sponsor Coverage practice which supports the complex financing needs of healthcare companies and private equity investors in the middle market.
Christopher Moniz
|
Market Manager, HealthTech & Devices
Chris is the Head of HealthTech & Medical Devices for the Northwest & Northeast markets.
Kate Walsh
|
Market Manager, Biopharma, Tools & Diagnostics
Kate is the Head of Biopharma, Tools & Diagnostics for the Northeast and San Francisco Bay Area markets.
Laura Scott
|
Senior Market Manager, Business Planning & Head of Mid-Atlantic & Southeast
Laura leads business planning for SVB's Life Science & Healthcare practice and oversees business development and relationship management in the Mid-Atlantic and Southeast markets.
Tom Hertzberg
|
Market Manager, Central & Southwest
Tom is the Head of SVB's Central US Life Science & Healthcare Banking, where he connects life-changing healthcare ideas with capital.
Ben Johnson
|
Head of Early Stage
Ben leads SVB’s seed stage life science and healthcare effort in the US, spending his time building relationships with early stage companies and key forces in the healthcare ecosystem.
Jennifer Friel Goldstein
|
Managing Partner, Life Science and Healthcare, SVB Capital
Jennifer is the managing partner for Life Science and Healthcare Practice at SVB Capital with more than 20 years of experience in the VC and startup market segments.
Anne Woods
|
Managing Director, Life Science & Healthcare
Anne leads SVB’s relationship with companies in Canada’s life science market and thrives on supporting these companies as they influence the next breakthrough.
Nooman Haque
|
Managing Director, Life Science & Healthcare
Nooman leads a team dedicated to supporting early, growth-stage and established EMEA and multinational businesses in all sectors of life sciences.
Healthcare innovators
SVB supports change-makers advancing the future of healthcare. While each may have different goals or objectives, the one thing they have in common is improving the state of healthcare and patient outcomes. Read their case studies to discover their innovations and learn how SVB has supported each on their path to growth.
BIOPHARMA
Mythic Therapeutics
Working together to target cancer
- “Silicon Valley Bank has been a great partner to us from the company’s earliest days, and our relationship has only evolved as we’ve grown. The team is courteous, respectful and has high-integrity. I would recommend them to any entrepreneur.”
Alex Nichols
President and CEO, Mythic Therapeutics
HEALTHTECH
Aledade
Improving healthcare, growing strong
- “SVB understands the complexities of our business and industry. They developed customized financing solutions for us, so we can keep our focus on helping physicians across the country deliver better care for their patients. We are thrilled with the results.”
Farzad Mostashari, M.D.
Founder and CEO, Aledade
BIOPHARMA
DICE Therapeutics
Pivoting for promise in psoriasis treatment
- “Silicon Valley Bank and SVB Leerink provide us with the financial services and support needed to accelerate our growth.”
Kevin Judice
CEO, DICE Therapeutics
MEDICAL DEVICE
Activ Surgical
Innovating a cutting-edge surgical tool
- “We’ve relied on SVB as our banking partner for years, and we were very pleased with the runway capital solutions they provided to take Activ to the next level. SVB knows us, the industry and our business.”
Todd Usen,
Chief Executive Officer, Activ Surgical
DIAGNOSTICS AND TOOLS
Xilis
Micro-tumor production grows hope in the fight against cancer
- “SVB has been a valued partner in our path to growth, coming in with the financial backing at the early stage enabling us to bring the vision of MicroOrganoSphere technology to life.”
Xiling Shen, Ph.D.
Co-founder & CEO, Xilis
Grow with confidence
The financial stress of unpredictable development timelines, regulations and reimbursement cycles can stand in the way of innovation and growth. SVB has the insights, guidance, and resources to help you scale effectively at every stage of growth.
Connect to the global SVB network
- Meet the VCs we work with
- Find your next hire through SVB's exclusive job board
- Get introduced to specialized service providers
SVB Leerink
- Define and achieve their strategic, capital markets and investment objectives
- Offering market intelligence and strategic advisory
- Drive connections with management teams and institutional investors
CipherBio
- Access to investing data based on indications
- Access to discover and navigate the life science ecosystem
- Ability to explore how your science is interconnected
SVB in China
Diversity, Equity & Inclusion Forum
- Access ideas from DE&I leaders
- Discover highly-relevant presentations
- Participate in the conversation
Strategies for Growth Beyond Series A: eBook
Innovate Next: Insights from leaders in healthcare
Access replays from the 2021 event featuring global leaders and experts taking healthcare to the next level.
They understand the value of relationships. They wanted my business when Twist was nobody.
Sophisticated solutions tailored to your lifestage
SVB Startup Banking
The banking, tools and access to reach your next round faster.
Learn more
SVB Leerink
SVB Leerink is a leading investment bank, specializing in healthcare and life sciences.
Learn more
SVB Asset Management
Helping high-growth clients achieve their investment objectives through exercising fiduciary care as a trusted advisor.
Learn more
Ready to get started?
See how SVB can help your business scale confidently for growth.
Insights from SVB Industry Experts
Proprietary insights to keep leaders on the cutting-edge of their sector and industry.
Report
Healthcare Investments and Exits
The SVB Healthcare Investments & Exits 2022 edition covers data for the entire year of 2021. Healthcare trends reveal venture fundraising almost doubled in 2021 over the previous year, with phenomenal growth across sectors: biopharma, healthtech, dx/tools, and device. Download the report for a deep dive into the current healthcare landscape and critical trends to watch.
Event
Healthcare Investments and Exits: Reshaping Healthcare After Covid-19
The pandemic created enormous disruption across the global economy. But few industries felt it more than healthcare — and life science innovators everywhere have responded to the challenge. Join SVB as we discuss and take questions on our latest Healthcare Investments and Exits Report.
Blog | Life Science & Healthcare
First quarter healthcare industry trends worth tracking
The article provides in-depth analysis of current healthcare industry trends for first quarter 2022 and the investment outlook for the rest of the year.
News | January 11, 2021
Report
Healthcare Investments and Exits Mid-Year 2021 Report
The pandemic has taught us resiliency. Economic activity in the healthcare market has translated into record venture fundraising, an acceleration in private investments in biopharma and healthtech and elevated IPO activity – ultimately changing the face of healthcare as we know it.
Blog | Life Science & Healthcare
Healthcare industry sectors: An overview of 2021
Get deep insights into the unprecedented activity in healthcare investments and exits by sector.
Blog | Life Science & Healthcare
Preview